Advisory Board & Investment Application

PathFree Technologies is transforming emergency heart care with our DataSyteAiCLS system. This technology assists medical professionals in performing CPR and advanced cardiovascular life support procedures with greater accuracy and speed, ultimately saving more lives.

Our AI-driven system provides real-time guidance, rhythm interpretation, and feedback, which reduces errors and improves patient outcomes during critical moments.

We are currently seeking advisory board members who are passionate about advancing healthcare technology and are interested in participating in our angel funding round. Your expertise and experience could be invaluable to our mission.

Responsibilities of Advisors & Investors:

* Provide feedback and guidance to the management team and other advisors (via email, Zoom) on company growth and strategies.

* Facilitate introductions to potential customers or partners.

Benefits to Advisors & Investors:

* Receive stock options in exchange for dedicating a few hours each month to the company.

* Opportunity to invest $25K+ as an angel via IRA/401K before valuation increases.

Consider joining us as an advisory board member and possible angel investor. Your expertise, introductions, and insights will be invaluable in helping us scale and save more lives.

If you are interested, please fill out this form below and our team will be in touch.

The Company shall be entitled to a 50% profits interest in any net profits realized by PathFree Technologies in connection with its inventions and intellectual property for a five (5) year term (the “Term”); and at the conclusion of the Term, Members of the Company holding Convertible Common Units shall have the right and option to either:

Receive a 100% return of their Capital Contribution to the Company (a “Redemption”); or

Convert their Units into shares of voting common stock in PathFree Technologies on a 1:1 basis (a “Conversion”, i.e., 1 Unit converts into 1 share).

Notwithstanding the foregoing, at their sole option, the Manager of the Company may effect either a Redemption or a Conversion of all of the Company’s outstanding Convertible Common Units in the event PathFree Technologies enters into any merger agreement or adopts a plan in which it or its successors or assigns either (a) is sold to a third-party purchaser; or (b) is to become listed or quoted on an established securities market or exchange (for example, NASDAQ, NYSE) or becomes readily tradable on a secondary market (or the substantial equivalent thereof) (i.e., a “Public Event”).

_{^{ATTENTION! THIS PAGE ONLY IS FOR ACCREDITED INVESTORS}}

---

See our Business Plan, Stonebridge Valuation, Offering Memorandum, and Investor Presentation below:

---

Please contact your PathFree Expansion LLC representative to receive a complete investors package, including digital subscription documents with instructions and options for funding your investment.

_{^{Contact us with questions or inquiries at: 1 (888) 83-PATHFREE}}

_{^{Email us at: info@pathfree.com}}